| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/03/2000 | CA2338561A1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | CA2338555A1 Live attenuated salmonella vaccines to control avian pathogens |
| 02/03/2000 | CA2338336A1 A novel g protein-coupled receptor protein and its dna thereof |
| 02/03/2000 | CA2338319A1 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 02/03/2000 | CA2338307A1 Pectic substance as a growth factor stabilizer |
| 02/03/2000 | CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | CA2337688A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | CA2337153A1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |
| 02/03/2000 | CA2337093A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 02/03/2000 | CA2336707A1 Xiap ires and uses thereof |
| 02/03/2000 | CA2336487A1 Copper transporter in ethylene signaling pathway |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2336225A1 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 02/03/2000 | CA2335655A1 Keratinocyte derived interferon |
| 02/03/2000 | CA2335653A1 Molecules associated with cell proliferation |
| 02/03/2000 | CA2335392A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | CA2335378A1 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 02/03/2000 | CA2335346A1 Sara proteins |
| 02/03/2000 | CA2335345A1 Human calcium regulatory proteins |
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/03/2000 | CA2335340A1 Fsh and fsh variant formulations, products and methods |
| 02/03/2000 | CA2335326A1 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | CA2335278A1 Method for screening of modulators of calcineurin activity |
| 02/03/2000 | CA2334947A1 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/03/2000 | CA2334042A1 Orphan cytokine receptor |
| 02/02/2000 | EP0977036A1 METHOD FOR ASSAYING AGALACTO-IgG AND ASSAY KITS, POLYPEPTIDES OF LECTINS, AND DNAS ENCODING THE SAME |
| 02/02/2000 | EP0976831A1 Method of genetic modification of a wild type viral sequence |
| 02/02/2000 | EP0976825A1 Transcriptional regulator |
| 02/02/2000 | EP0976824A1 Gene and protein involved in liver regeneration |
| 02/02/2000 | EP0976823A1 Recombinant expression system and high throughput BioAssay for the therapeutic use of calcineurine-A- alpha, calcineurine-A-beta, calcineurine-A-gamma, calcineurine-B und Cu/Zn-superoxide dismutase respectively for the identification of pharmaceuticals |
| 02/02/2000 | EP0976765A1 Process for the preparation of a protein solution |
| 02/02/2000 | EP0976764A1 Novel membrane-secreted protein |
| 02/02/2000 | EP0976763A1 Antigens and immunoassays for diagnosing Chagas' disease |
| 02/02/2000 | EP0976759A2 Preparation of protein formulations with reduced content of aggregates |
| 02/02/2000 | EP0976331A2 Soybean protein hydrolysates, their production and use |
| 02/02/2000 | EP0975972A1 Methods for identifying cell cycle regulators |
| 02/02/2000 | EP0975954A1 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules |
| 02/02/2000 | EP0975809A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 02/02/2000 | EP0975801A1 METHODS FOR SCREENING FOR ANTIMICROBIALS UTILIZING (aarC) AND COMPOSITIONS THEREOF |
| 02/02/2000 | EP0975798A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 02/02/2000 | EP0975793A1 Interactions of skn7 gene and its use in assay methods |
| 02/02/2000 | EP0975786A2 Novel transgene expression system for increased persistence |
| 02/02/2000 | EP0975784A2 Herpes simplex virus u s?3 and icp4 as inhibitors of apoptosis |
| 02/02/2000 | EP0975782A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression |
| 02/02/2000 | EP0975780A2 Il-2 gene expression and delivery systems and uses |
| 02/02/2000 | EP0975779A1 Oxidative stress resistance gene |
| 02/02/2000 | EP0975777A1 Methods of commercial production and extraction of protein from seed |
| 02/02/2000 | EP0975776A1 Gene involved in basidiomycete fungi fruit body development and uses |
| 02/02/2000 | EP0975775A2 Regulatory system for inducible expression of genes with lambdoid promoters |
| 02/02/2000 | EP0975773A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 02/02/2000 | EP0975772A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 02/02/2000 | EP0975771A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 02/02/2000 | EP0975764A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 02/02/2000 | EP0975763A1 Bacillus thuringiensis isolates with broad spectrum activity |
| 02/02/2000 | EP0975762A1 Type-1 ribosome-inactivating protein |
| 02/02/2000 | EP0975761A1 Recombinant human beta interferon with enhanced solubility |
| 02/02/2000 | EP0975760A1 Motilin homologs |
| 02/02/2000 | EP0975759A1 Human tumor-associated kazal inhibitor |
| 02/02/2000 | EP0975758A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/02/2000 | EP0975757A2 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
| 02/02/2000 | EP0975755A1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 02/02/2000 | EP0975754A1 Osteoprotegerin binding proteins and receptors |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975752A1 Human cerberus protein |
| 02/02/2000 | EP0975751A1 A tm4sf human tumor-associated antigen |
| 02/02/2000 | EP0975750A2 Modified retinoblastoma tumor suppressor proteins |
| 02/02/2000 | EP0975749A2 Cc chemokine receptor 5, antibodies thereto, transgenic animals |
| 02/02/2000 | EP0975747A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
| 02/02/2000 | EP0975746A1 Transgenic mouse expressing human cd4 and fusin (cxcr4) |
| 02/02/2000 | EP0975745A1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/02/2000 | EP0975743A1 Inhibitors for urokinase receptor |
| 02/02/2000 | EP0975742A1 Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins |
| 02/02/2000 | EP0975737A1 $i(CHLORELLA) VIRUS PROMOTERS |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975671A1 Method of chromatographically purifying or fractionating von willebrand factor from a vwf-containing starter material |
| 02/02/2000 | EP0975670A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
| 02/02/2000 | EP0975669A1 Calcitonin receptor-binding peptides |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975667A1 METHODS OF DIAGNOSING CLINICAL SUBTYPES OF CROHN'S DISEASE WITH CHARACTERISTIC RESPONSIVENESS TO ANTI-Th1 CYTOKINE THERAPY |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/02/2000 | EP0975665A1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 02/02/2000 | EP0975664A1 Aatt promoter element and transcription factor |
| 02/02/2000 | EP0975663A1 Helicobacter pylori antigens |
| 02/02/2000 | EP0975660A2 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN alpha-CATENIN and beta-CATENIN |
| 02/02/2000 | EP0975657A1 Method of purifying protein from inclusion bodies |
| 02/02/2000 | EP0975654A1 Composition and method for treatment of cmv infections |
| 02/02/2000 | EP0975652A1 CAP-BINDING DOMAIN OF HUMAN EUKARYOTIC PROTEIN SYNTHESIS INITIATION FACTOR eIF-4E AND THE USE THEREOF |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975374A1 Radiometal-binding peptide analogues |
| 02/02/2000 | EP0975365A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms |
| 02/02/2000 | EP0975359A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/02/2000 | EP0866859A4 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 02/02/2000 | EP0839205B1 Liver-specific adenovirus expression vector |
| 02/02/2000 | EP0809509A4 Allosteric control of nuclear hormone receptors |
| 02/02/2000 | EP0752472B1 Gene originating in corynebacterium and use thereof |
| 02/02/2000 | EP0729580B1 Method of identifying hdm-2-specific antibodies |
| 02/02/2000 | EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |